Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cahayasakti Investindo Sukses Tbk. (CSIS) vs Merck Tbk. (MERK) Price & Performance

Cahayasakti Investindo Sukses Tbk.Trade
Merck Tbk.Trade

Price performance (Past 24H)

Key statistics

Cahayasakti Investindo Sukses Tbk. vs Merck Tbk. — how do they compare? Cahayasakti Investindo Sukses Tbk. trades at Rp163 (market cap 294.6B, 1.22M 24h volume), while Merck Tbk. trades at Rp3,800 (market cap 1.68T, 33.3K 24h volume). The key difference: Merck Tbk. is far larger — about 5.7× Cahayasakti Investindo Sukses Tbk.'s market cap, and Cahayasakti Investindo Sukses Tbk. is more actively traded (1.22M versus 33.3K). Which is the better fit depends on your goals.

CSISMERK
Market Cap
294.6B1.68T
Volume
1.22M33.3K
Lot
12.24K333
Turnover
199.03M126.46M
Average Price
162.683,797.72
Value
199.03M126.46M
Indicative Equilibrium Price
1633,800
Indicative Equilibrium Volume
1869

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

CSIS
View details
MERK
View details

About Cahayasakti Investindo Sukses Tbk.

PT Cahayasakti Investindo Sukses Tbk (the Company) was established based on the Deed of Notary Djurnawati Soetarmono, SH, No. 52 dated June 2, 1995. The Company belongs to a group of companies owned by PT Andalan Utama Bintara.

Read more on CSIS

About Merck Tbk.

PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.

Read more on MERK